288 related articles for article (PubMed ID: 28107481)
21. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.
Lu F; Day L; Gao SJ; Lieberman PM
J Virol; 2006 Jun; 80(11):5273-82. PubMed ID: 16699007
[TBL] [Abstract][Full Text] [Related]
22. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
Lu J; Verma SC; Cai Q; Robertson ES
J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
[TBL] [Abstract][Full Text] [Related]
24. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
25. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
[TBL] [Abstract][Full Text] [Related]
26. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Hopcraft SE; Pattenden SG; James LI; Frye S; Dittmer DP; Damania B
PLoS Pathog; 2018 Sep; 14(9):e1007267. PubMed ID: 30212584
[TBL] [Abstract][Full Text] [Related]
27. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs.
Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
29. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
Tso FY; West JT; Wood C
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.
Kang H; Lieberman PM
J Virol; 2009 Jun; 83(12):6199-210. PubMed ID: 19369356
[TBL] [Abstract][Full Text] [Related]
31. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
32. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
33. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.
Kang H; Wiedmer A; Yuan Y; Robertson E; Lieberman PM
PLoS Pathog; 2011 Aug; 7(8):e1002140. PubMed ID: 21876668
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.
Zhang YJ; Wang KY; Stein DA; Patel D; Watkins R; Moulton HM; Iversen PL; Matson DO
Antiviral Res; 2007 Jan; 73(1):12-23. PubMed ID: 16842866
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
Verma SC; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter.
Elbasani E; Falasco F; Gramolelli S; Nurminen V; Günther T; Weltner J; Balboa D; Grundhoff A; Otonkoski T; Ojala PM
Viruses; 2020 Aug; 12(9):. PubMed ID: 32867368
[TBL] [Abstract][Full Text] [Related]
37. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
[TBL] [Abstract][Full Text] [Related]
38. A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.
Hellert J; Weidner-Glunde M; Krausze J; Richter U; Adler H; Fedorov R; Pietrek M; Rückert J; Ritter C; Schulz TF; Lührs T
PLoS Pathog; 2013; 9(10):e1003640. PubMed ID: 24146614
[TBL] [Abstract][Full Text] [Related]
39. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
40. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
